403 related articles for article (PubMed ID: 31830541)
1. Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis.
Zhao L; Gu C; Gan Y; Shao L; Chen H; Zhu H
J Control Release; 2020 Feb; 318():1-15. PubMed ID: 31830541
[TBL] [Abstract][Full Text] [Related]
2. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Han J; Wang Q; Zhang Z; Gong T; Sun X
Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis.
Pan R; He T; Zhang K; Zhu L; Lin J; Chen P; Liu X; Huang H; Zhou D; Li W; Yang S; Ye G
Cell Mol Bioeng; 2023 Apr; 16(2):117-125. PubMed ID: 37096069
[TBL] [Abstract][Full Text] [Related]
4. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
Liu R; Xiao W; Hu C; Xie R; Gao H
J Control Release; 2018 May; 278():127-139. PubMed ID: 29630985
[TBL] [Abstract][Full Text] [Related]
5. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
6. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer.
Li S; Wu Y; Ding F; Yang J; Li J; Gao X; Zhang C; Feng J
Nanoscale; 2020 May; 12(19):10854-10862. PubMed ID: 32396590
[TBL] [Abstract][Full Text] [Related]
7. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
[TBL] [Abstract][Full Text] [Related]
8. Critical Review on the Different Roles of Exosomes in TNBC and Exosomal-Mediated Delivery of microRNA/siRNA/lncRNA and Drug Targeting Signalling Pathways in Triple-Negative Breast Cancer.
Banerjee M; Rajeswari VD
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838790
[TBL] [Abstract][Full Text] [Related]
9. Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer.
Parvani JG; Gujrati MD; Mack MA; Schiemann WP; Lu ZR
Cancer Res; 2015 Jun; 75(11):2316-2325. PubMed ID: 25858145
[TBL] [Abstract][Full Text] [Related]
10. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
Huang X; Guo H; Wang L; Zhang Z; Zhang W
Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
[TBL] [Abstract][Full Text] [Related]
12. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
[TBL] [Abstract][Full Text] [Related]
13. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment.
Liu R; Hu C; Yang Y; Zhang J; Gao H
Acta Pharm Sin B; 2019 Mar; 9(2):410-420. PubMed ID: 30976492
[TBL] [Abstract][Full Text] [Related]
14. Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells.
Ferreira D; Santos-Pereira C; Costa M; Afonso J; Yang S; Hensel J; McAndrews KM; Longatto-Filho A; Fernandes R; Melo JB; Baltazar F; Moreira JN; Kalluri R; Rodrigues LR
Biomater Adv; 2023 Nov; 154():213643. PubMed ID: 37778291
[TBL] [Abstract][Full Text] [Related]
15. Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS.
Yu P; Han Y; Meng L; Tian Y; Jin Z; Luo J; Han C; Xu W; Kong L; Zhang C
Acta Pharm Sin B; 2024 May; 14(5):2039-2056. PubMed ID: 38799644
[TBL] [Abstract][Full Text] [Related]
16. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
[TBL] [Abstract][Full Text] [Related]
17. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition.
Wang K; Ye H; Zhang X; Wang X; Yang B; Luo C; Zhao Z; Zhao J; Lu Q; Zhang H; Kan Q; Wang Y; He Z; Sun J
Biomaterials; 2020 Oct; 257():120224. PubMed ID: 32736255
[TBL] [Abstract][Full Text] [Related]
18. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
19. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
20. Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform.
Morry J; Ngamcherdtrakul W; Gu S; Reda M; Castro DJ; Sangvanich T; Gray JW; Yantasee W
Mol Cancer Ther; 2017 Apr; 16(4):763-772. PubMed ID: 28138033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
